Cambium Bio Limited (ASX:CMB) has lodged a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth), disclosing the issue of 14,791,667 ordinary shares without disclosure to investors under Part 6D.2 of the Corporations Act, with the notice dated 18 November 2026.

Key Points

  • Cambium Bio Limited issued 14,791,667 ordinary shares without disclosure to investors under Part 6D.2 of the Corporations Act.
  • The company confirmed compliance with the provisions of Chapter 2M of the Corporations Act as they apply to the company as at the date of the notice.
  • The company confirmed compliance with section 674 of the Corporations Act as at the date of the notice.
  • The company stated there is no excluded information as defined in subsections 708A(7) and 708A(8) of the Corporations Act required to be disclosed.

Cleansing Notice Under Section 708A of the Corporations Act

Cambium Bio Limited filed a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) on 18 November 2026. The filing states that the company has issued 14,791,667 ordinary shares without disclosure to investors under Part 6D.2 of the Corporations Act. The cleansing notice serves to satisfy the requirements of the Corporations Act in connection with the share issue. According to the filing, an Appendix 2A with respect to the issue has been lodged with the ASX. The notice was authorised for release by the Board of Directors of Cambium Bio Limited.

Regulatory Compliance Declarations as at Notice Date

As at the date of the notice, Cambium Bio Limited declared compliance with two specific regulatory provisions. The company confirmed it has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the company, which relates to financial reporting obligations. The company also confirmed compliance with section 674 of the Corporations Act, which concerns continuous disclosure obligations. Both declarations were made as at 18 November 2026, the date of the cleansing notice, as stated in the filing.

No Excluded Information Disclosed by the Company

The filing states that as at the date of the notice, there is no excluded information as defined in subsections 708A(7) and 708A(8) of the Corporations Act that is required to be disclosed by the company. This declaration forms a required component of the cleansing notice lodged under section 708A(5)(e). The notice was signed by Olga Smejkalova in her capacity as Company Secretary of Cambium Bio Limited and was authorised for release by the company's Board of Directors.